All articles published by MDPI are made immediately available worldwide under an open access license. No special
permission is required to reuse all or part of the article published by MDPI, including figures and tables. For
articles published under an open access Creative Common CC BY license, any part of the article may be reused without
permission provided that the original article is clearly cited. For more information, please refer to
https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature
Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for
future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive
positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
Editors select a small number of articles recently published in the journal that they believe will be particularly
interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the
most exciting work published in the various research areas of the journal.
The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 22nd year, will be held at the Hilton Universal Hotel Los Angeles in Universal City, CA, on 12–14 December, 2024. It is a unique and exciting multidisciplinary CME conference. The congress has become the leading global meeting dedicated to diabetes, obesity, lipids, cardiovascular–kidney, and liver disease linking basic research to clinical practice in pursuit of our theme “Exploring New Frontiers in Metabolism—Tomorrow’s Clinical Science Today”. WCIRDC offers attendees a unique experience to interact with the distinguished global faculty. In an intimate setting, participants can expect a collaborative experience that explores the newest understanding of metabolic diseases and the development of future therapeutic modalities. Registration is now open.
On behalf of the organizing committee, we warmly welcome you to participate in the 3rd Global Congress on Cardiology (GCC 2025), which will be held on Mar 27th–29th, 2025, in Kyoto, Japan, with a hybrid format.
GCC 2025 includes 11 breakout sessions and a poster exhibition during the three-day scientific program. The main topics include Heart Failure and Cardiac Arrhythmias, Cardiovascular Pharmacology, Arteriosclerosis, Pediatric Cardiology, Clinical Cardiology, etc. Please check more information about the conference through the link: https://gcc2025.lmsii.org/
GCC 2025 brings together the best scientists from universities, research institutes, and hospitals worldwide to share exciting results and to build new collaborations.
We hope you can join your peers at a highly interesting and engaging hybrid event with online and offline formats. Your presence and participation will make this congress a success.